Vista Capital Partners Inc. acquired a new position in shares of Tilray Inc (NASDAQ:TLRY – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 24,074 shares of the company’s stock, valued at approximately $42,000.
Other institutional investors have also recently modified their holdings of the company. Tidal Investments LLC boosted its stake in shares of Tilray by 36,687.0% during the 1st quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after purchasing an additional 10,648,403 shares during the last quarter. Vanguard Group Inc. grew its stake in Tilray by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after acquiring an additional 117,891 shares during the period. Bank of Montreal Can raised its holdings in Tilray by 19.6% in the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after acquiring an additional 355,778 shares during the last quarter. Swiss National Bank lifted its stake in shares of Tilray by 3.6% during the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock worth $3,683,000 after purchasing an additional 51,700 shares during the period. Finally, TD Asset Management Inc boosted its holdings in shares of Tilray by 8.1% during the second quarter. TD Asset Management Inc now owns 1,373,045 shares of the company’s stock worth $2,278,000 after purchasing an additional 103,207 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.
Tilray Stock Up 0.6 %
Shares of TLRY opened at $1.55 on Friday. Tilray Inc has a twelve month low of $1.45 and a twelve month high of $2.97. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The stock’s fifty day simple moving average is $1.68 and its 200 day simple moving average is $1.79.
Wall Street Analyst Weigh In
Separately, Roth Mkm dropped their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.
Get Our Latest Analysis on TLRY
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
Featured Articles
- Five stocks we like better than Tilray
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Take-Two Interactive’s 2024 Comeback: New Highs Expected in 2025
- ETF Screener: Uses and Step-by-Step Guide
- How Altimmune Could Grab a Big Chunk of the GLP-1 Market
- What is the Shanghai Stock Exchange Composite Index?
- Here’s Why Etsy Management Is Investing $1 Billion in Buybacks
Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRY – Free Report).
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.